课题基金 / 基金详情

HUMAN LEUKEMIA ANTIGENS: ISOLATION AND CHARACTERIZATION

HUMAN LEUKEMIA ANTIGENS: ISOLATION AND CHARACTERIZATION
人类白血病抗原:分离和表征
批准号:
3166846
负责人:
STUART F SCHLOSSMAN
金额:
$28.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-06-01 至 1989-05-31

项目摘要

项目成果

STUART F SCHLOSSMAN的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The immunologic characterization of leukemic and lymphoma cells has facilitated investigations designed to improve our understanding of the heterogeneity and pathophysiology of human leukemias and lymphomas. We have undertaken studies to characterize leukemic and lymphoma cell surface antigens with monoclonal antibodies produced by somatic cell hybridization techniques. These antibodies have proven useful for the definition of both the heterogeneity and lineage of leukemia and lymphoma cells and in defining their states of differentiation. The identification of unique cell surface antigens by serologic techniques has allowed for the rapid diagnosis and distinction of a variety of T, B, and myeloid cell leukemias from one another. Moreover, these unique cell surface profiles have permitted the development and an understanding of the relationship of the leukemic cell to states of normal T, B, and myeloid cell differentiation. The antibodies to leukemic cells have permitted the development of rapid assays for the classification and characterization of leukemias and lymphomas in man. More importantly, the identification of homogeneous leukemic and lymphoma phenotypes has led to the use of these reagents in both the diagnosis of individual malignancies and the selection of appropriate antibodies for the treatment of these disorders by autologous and mismatched transplantation. The demonstration that anti-CALLA (J5) was reactive with the majority of non-T cell leukemias and anti-Bl was reactive with most B-cell lymphomas has encouraged the use of these antibodies in marrow cleansing in autologous bone marrow transplantation. Long-term remissions have been obtained with a combination of bone marrow cleanup and aggressive chemotherapy. Thus, considerable progress has been made during the past year in the utilization of specific monoclonal antibodies for the diagnosis of leukemias and lymphomas and, more importantly, for the specific therapy of these diseases. (L8)
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Immunologic heterogeneity of diffuse large cell lymphoma.
弥漫性大细胞淋巴瘤的免疫异质性。
DOI: --
发表时间: 1985
期刊: Blood
影响因子: 20.3
作者: [Freedman,AS, Boyd,AW, Anderson,KC, Fisher,DC, Pinkus,GS, Schlossman,SF, Nadler,LM]
通讯作者: Nadler,LM
Response patterns of purified myeloma cells to hematopoietic growth factors.
纯化的骨髓瘤细胞对造血生长因子的反应模式。
DOI: --
发表时间: 1989
期刊: Blood
影响因子: 20.3
作者: [Anderson,KC, Jones,RM, Morimoto,C, Leavitt,P, Barut,BA]
通讯作者: Barut,BA
DOI: 10.4049/jimmunol.143.11.3430
发表时间: 1989-12
期刊: Journal of immunology
影响因子: 4.4
作者: [C. Morimoto;Y. Torimoto;G. Levinson;C. Rudd;M. Schrieber;N. Dang;N. Letvin;S. Schlossman]
通讯作者: C. Morimoto;Y. Torimoto;G. Levinson;C. Rudd;M. Schrieber;N. Dang;N. Letvin;S. Schlossman
Novel approach to construction of human "myeloma analogues" for production of human monoclonal antibodies.
构建人类“骨髓瘤类似物”以生产人类单克隆抗体的新方法。
DOI: 10.1089/hyb.1983.2.369
发表时间: 1983
期刊: Hybridoma
影响因子: --
作者: [Posner,MR, Schlossman,SF, Lazarus,H]
通讯作者: Lazarus,H
PROGRAM OF STUDIES ON THE BIOLOGY AND TREATMENT OF HUMAN
  • 批准号:
    2088639
  • 项目类别:
  • 资助金额:
    $224.82万
  • 财政年份:
    1983
  • 负责人:
    STUART F SCHLOSSMAN
  • 依托单位:
PROGRAM OF STUDIES ON THE BIOLOGY AND TREATMENT OF HUMAN
  • 批准号:
    3093534
  • 项目类别:
  • 资助金额:
    $221.61万
  • 财政年份:
    1983
  • 负责人:
    STUART F SCHLOSSMAN
  • 依托单位:
THE BIOLOGY AND TREATMENT OF HUMAN LEUKEMIA AND
  • 批准号:
    3093531
  • 项目类别:
  • 资助金额:
    $141.34万
  • 财政年份:
    1983
  • 负责人:
    STUART F SCHLOSSMAN
  • 依托单位:
THE BIOLOGY AND TREATMENT OF HUMAN LEUKEMIA AND LYMPHOMA
  • 批准号:
    3093532
  • 项目类别:
  • 资助金额:
    $151.38万
  • 财政年份:
    1983
  • 负责人:
    STUART F SCHLOSSMAN
  • 依托单位: